Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 12;15(3):e36039.
doi: 10.7759/cureus.36039. eCollection 2023 Mar.

A Case of Thrombotic Thrombocytopenic Purpura and ST-Elevation Myocardial Infarction: An Unusual Correlation

Affiliations
Case Reports

A Case of Thrombotic Thrombocytopenic Purpura and ST-Elevation Myocardial Infarction: An Unusual Correlation

Adekunle E Omole et al. Cureus. .

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare and potentially devastating blood disorder depicted by thrombocytopenia, fever, widespread small vessel hemolytic anemia, and neurological symptoms. The involvement of the renal and neurological systems is frequently reported in TTP; however, TTP-induced acute coronary syndrome is not widely reported. We describe a case of myocardial infarction induced by TTP in a patient who presented with the typical manifestation of acute coronary syndrome. Echocardiogram revealed a myocardial injury, and detailed investigations revealed increased levels of troponin I, lactate dehydrogenase, diminished levels of haptoglobin and von Willebrand factor-cleaving protease, and schistocytes on peripheral smear, suggestive of TTP-induced myocardial infarction. His condition was stabilized after commencing plasmapheresis, steroids, and rituximab. The initial steps in the management of this patient involve the prompt administration of steroids and the urgent start of plasmapheresis to increase platelet count.

Keywords: acquired ttp; acute coronary syndrome; acute thrombotic microangiopathy; myocardial infarction; thrombotic thrombocytopenic purpura; ttp.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Electrocardiograph demonstrating ST-segment elevation in leads 2, 3, and aVF with reciprocal changes in the aVL lead
aVF- Augmented vector Foot; aVL- Augmented vector Left
Figure 2
Figure 2. Trend of platelet count and serum creatinine during the hospital stay

Similar articles

References

    1. Autoimmune thrombotic microangiopathy: advances in pathogenesis, diagnosis, and management. Tsai HM. Semin Thromb Hemost. 2012;38:469–482. - PubMed
    1. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Hawkins BM, Abu-Fadel M, Vesely SK, George JN. Transfusion. 2008;48:382–392. - PubMed
    1. Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed? Nichols L, Berg A, Rollins-Raval MA, Raval JS. Ther Apher Dial. 2015;19:87–92. - PubMed
    1. Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: a single-center experience. Gandhi K, Aronow WS, Desai H, Amin H, Sharma M, Lai HM, Singh P. Clin Cardiol. 2010;33:213–216. - PMC - PubMed
    1. Fatal cardiac arrhythmia in a patient with thrombotic thrombocytopenic purpura. Arnold PO, Klink D, Holmes AK. Am J Med Sci. 2006;331:320–321. - PubMed

Publication types

LinkOut - more resources